Wolverine Trading
VNDA icon

Wolverine Trading’s Vanda Pharmaceuticals VNDA Stock Holding History

Wolverine Trading’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,400
Closed -$54.5K – 5931
2024
Q4 		$54.5K Sell
11,400
-3,600
-24% -$17.3K ﹤0.01% 4966
2024
Q3 		$70K Sell
15,000
-66,200
-82% -$355K ﹤0.01% 4457
2024
Q2 		$459K Buy
+81,200
New +$419K ﹤0.01% 2926
2021
Q3 		– Sell
-10,800
Closed -$220K – 7029
2021
Q2 		$220K Buy
+10,800
New +$193K ﹤0.01% 4890
2019
Q3 		– Sell
-15,900
Closed -$224K – 5087
2019
Q2 		$224K Sell
15,900
-14,200
-47% -$226K ﹤0.01% 3597
2019
Q1 		$554K Sell
30,100
-2,500
-8% -$57K ﹤0.01% 2657
2018
Q4 		$837K Buy
32,600
+18,100
+125% +$426K ﹤0.01% 2132
2018
Q3 		$333K Sell
14,500
-500
-3% -$10.2K ﹤0.01% 3621
2018
Q2 		$253K Hold
15,000
– – ﹤0.01% 4033
2018
Q1 		$253K Buy
+15,000
New +$251K ﹤0.01% 4033
2017
Q1 		– Sell
-17,400
Closed -$278K – 5065
2016
Q4 		$278K Sell
17,400
-26,700
-61% -$429K ﹤0.01% 3346
2016
Q3 		$717K Buy
44,100
+29,400
+200% +$396K ﹤0.01% 2221
2016
Q2 		$163K Buy
+14,700
New +$142K ﹤0.01% 3407

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Wolverine Trading's VNDA Position: Q3 2025 in Review

Wolverine Trading sold out of Vanda Pharmaceuticals (VNDA) in Q3 2025, closing a stake of 11,417 shares — an estimated $54.6K sold.

Wolverine Trading first reported a position in VNDA in Q2 2016 and held it in 6 quarters. The position peaked at $235K in Q1 2019. 150 funds tracked by Wall St. Rank hold VNDA as of Q3 2025.

  • Wolverine Trading reported no remaining Vanda Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 11,417 Vanda Pharmaceuticals shares in Q3 2025, an estimated $54.6K.
  • Wolverine Trading first reported a position in Vanda Pharmaceuticals in Q2 2016 and held it in 6 quarters.
  • Wolverine Trading's Vanda Pharmaceuticals position peaked at $235K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.